PMO Interview with the Innovator Series: Volume 1

Video Categories: PMO Interview with the Innovator Series

Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.

Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, Inc.
April 14, 2015

Managing Costs in Oncology Care

Dr. Boccia talks about the importance of controlling costs in the current environment and how the bioT3 testing approach can help compared to other options.

September 2, 2015

Changing the Way Takeda Oncology Develops Cancer Medicines

Dixie-Lee Esseltine, MD and George Mulligan, PhD offer insight on the impact of ixazomib on Takeda Oncology’s approach to multiple myeloma care and its approach to other cancer types.